These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 18595523)
21. [The effect of desloratadine on quality of life of patients with seasonal allergic rhinitis]. Li Y; Liu F Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 May; 22(10):439-42. PubMed ID: 18720881 [TBL] [Abstract][Full Text] [Related]
22. [The place of new antihistamines in allergy management. Apropos of desloratadine]. Sabbah A Allerg Immunol (Paris); 2002 Dec; 34(10):377-83. PubMed ID: 12575624 [TBL] [Abstract][Full Text] [Related]
23. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy. Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441 [TBL] [Abstract][Full Text] [Related]
24. The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years. Salmun LM; Herron JM; Banfield C; Padhi D; Lorber R; Affrime MB Clin Ther; 2000 May; 22(5):613-21. PubMed ID: 10868558 [TBL] [Abstract][Full Text] [Related]
25. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis. Bachert C Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095 [TBL] [Abstract][Full Text] [Related]
26. [Antihistaminics. Side effects also after raising dosage at the placebo level]. MMW Fortschr Med; 2003 May; 145(22):50-1. PubMed ID: 12866280 [No Abstract] [Full Text] [Related]
27. [Oral second generation antihistamines in allergic rhinitis]. Riechelmann H Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976 [TBL] [Abstract][Full Text] [Related]
28. Comparison of efficacy, safety, and skin test inhibition of cetirizine and astemizole. Berkowitz RB; Dockhorn R; Lockey R; Findlay S; Howland WC; Mitchell DQ; Woehler T Ann Allergy Asthma Immunol; 1996 Apr; 76(4):363-8. PubMed ID: 8612120 [TBL] [Abstract][Full Text] [Related]
29. Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis. Prevost M; Turenne Y; Moote DW; Mazza J; Clermont A; PetitClerc C; Danzig MR Clin Ther; 1994; 16(1):50-6. PubMed ID: 7911402 [TBL] [Abstract][Full Text] [Related]
30. The efficacy and tolerability of two novel H(1)/H(3) receptor antagonists in seasonal allergic rhinitis. Daley-Yates P; Ambery C; Sweeney L; Watson J; Oliver A; McQuade B Int Arch Allergy Immunol; 2012; 158(1):84-98. PubMed ID: 22212854 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders. Prenner BM; Capano D; Harris AG Clin Ther; 2000 Jun; 22(6):760-9. PubMed ID: 10929922 [TBL] [Abstract][Full Text] [Related]
32. Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus cetirizine in the treatment of seasonal allergic rhinitis. Horak F; Stübner P; Zieglmayer R; Kavina A; Corrado ME; Assandri A; Mion A Arzneimittelforschung; 2004; 54(10):666-72. PubMed ID: 15553106 [TBL] [Abstract][Full Text] [Related]
33. [Clinical research of Ibudilast on treating the steroid resistant allergic rhinitis]. Luo H; Tao Z; Yan N; Liang J; Wang P; Wang J Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 23(2):63-6. PubMed ID: 19452709 [TBL] [Abstract][Full Text] [Related]
34. Onset of action of loratadine and placebo and other efficacy variables in patients with seasonal allergic rhinitis. Bédard PM; Del Carpio J; Drouin MA; Yang W; Hébert J; Lavoie A; Prévost M; Turenne Y; PetitClerc C; Lorber R Clin Ther; 1992; 14(2):268-75. PubMed ID: 1351796 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients. Bachert C; Kuna P; Sanquer F; Ivan P; Dimitrov V; Gorina MM; van de Heyning P; Loureiro A; Allergy; 2009 Jan; 64(1):158-65. PubMed ID: 19132976 [TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis. Meltzer EO; Hampel FC; Ratner PH; Bernstein DI; Larsen LV; Berger WE; Finn AF; Marple BF; Roland PS; Wall GM; Brubaker MJ; Dimas C; Potts SL; Silver LH; Barnes JR Ann Allergy Asthma Immunol; 2005 Dec; 95(6):600-6. PubMed ID: 16400902 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. LaForce CF; Corren J; Wheeler WJ; Berger WE; Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675 [TBL] [Abstract][Full Text] [Related]
38. [Evaluation of the efficiency and safety of the loratadine with pseudoephedrine combination drug in treatment of seasonal allergic rhinitis]. Zawisza E; Lipiec A; Rapiejko P Pol Merkur Lekarski; 1998 Feb; 4(20):66-8. PubMed ID: 9634291 [TBL] [Abstract][Full Text] [Related]
39. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge. Georgitis JW; Meltzer EO; Kaliner M; Weiler J; Berkowitz R Ann Allergy Asthma Immunol; 2000 Apr; 84(4):451-9. PubMed ID: 10795655 [TBL] [Abstract][Full Text] [Related]
40. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis. Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]